138 related articles for article (PubMed ID: 29628128)
1. Impact of Baseline Thrombocytopenia on Bleeding and Mortality After Percutaneous Coronary Intervention.
Ito S; Watanabe H; Morimoto T; Yoshikawa Y; Shiomi H; Shizuta S; Ono K; Yamaji K; Soga Y; Hyodo M; Shirai S; Ando K; Horiuchi H; Kimura T
Am J Cardiol; 2018 Jun; 121(11):1304-1314. PubMed ID: 29628128
[TBL] [Abstract][Full Text] [Related]
2. Incidence and Impact of Thrombocytopenia in Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents.
Park S; Ahn JM; Kim TO; Park H; Cho SC; Kang DY; Lee PH; Park DW; Park SJ;
Am J Cardiol; 2020 Nov; 134():55-61. PubMed ID: 32891400
[TBL] [Abstract][Full Text] [Related]
3. Ischemic and Bleeding Risk After Percutaneous Coronary Intervention in Patients With Prior Ischemic and Hemorrhagic Stroke.
Natsuaki M; Morimoto T; Watanabe H; Nakagawa Y; Furukawa Y; Kadota K; Akasaka T; Hanaoka KI; Kozuma K; Tanabe K; Morino Y; Muramatsu T; Kimura T;
J Am Heart Assoc; 2019 Nov; 8(22):e013356. PubMed ID: 31701821
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Impact of Baseline Hemoglobin Levels on Long-Term Thrombotic and Bleeding Events After Percutaneous Coronary Interventions.
Nagao K; Watanabe H; Morimoto T; Inada T; Hayashi F; Nakagawa Y; Furukawa Y; Kadota K; Akasaka T; Natsuaki M; Kozuma K; Tanabe K; Morino Y; Shiomi H; Kimura T;
J Am Heart Assoc; 2019 Nov; 8(22):e013703. PubMed ID: 31701786
[TBL] [Abstract][Full Text] [Related]
5. Serum Albumin and Bleeding Events After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction (from the HAGAKURE-ACS Registry).
Yoshioka G; Natsuaki M; Goriki Y; Shinzato K; Nishihira K; Kuriyama N; Shimomura M; Inoue Y; Nishikido T; Hongo H; Kaneko T; Kamishita K; Yokoi K; Yajima A; Sakamoto Y; Tago M; Kawaguchi A; Yamaguchi T; Asaka M; Kotooka N; Sonoda S; Hikichi Y; Shibata Y; Node K
Am J Cardiol; 2022 Feb; 165():19-26. PubMed ID: 34893303
[TBL] [Abstract][Full Text] [Related]
6. Relation of White Blood Cell Count to Bleeding and Ischemic Events in Patients With Acute Coronary Syndrome (from the ATLAS ACS 2-TIMI 51 Trial).
Alkhalfan F; Nafee T; Yee MK; Chi G; Kalayci A; Plotnikov A; Braunwald E; Gibson CM
Am J Cardiol; 2020 Mar; 125(5):661-669. PubMed ID: 31898965
[TBL] [Abstract][Full Text] [Related]
7. Influence of Baseline Platelet Count on Outcomes in Patients With Venous Thromboembolism (from the COMMAND VTE Registry).
Yamashita Y; Morimoto T; Amano H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Saga S; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Watanabe H; Shiomi H; Kato T; Makiyama T; Ono K; Kimura T;
Am J Cardiol; 2018 Dec; 122(12):2131-2141. PubMed ID: 30293653
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of bleeding academic research consortium (BARC)-defined bleeding complications in ST-segment elevation myocardial infarction: a comparison with the TIMI (Thrombolysis In Myocardial Infarction), GUSTO (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries), and ISTH (International Society on Thrombosis and Haemostasis) bleeding classifications.
Kikkert WJ; van Geloven N; van der Laan MH; Vis MM; Baan J; Koch KT; Peters RJ; de Winter RJ; Piek JJ; Tijssen JG; Henriques JP
J Am Coll Cardiol; 2014 May; 63(18):1866-75. PubMed ID: 24657697
[TBL] [Abstract][Full Text] [Related]
9. Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: a report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2.
Tokushige A; Shiomi H; Morimoto T; Ono K; Furukawa Y; Nakagawa Y; Kadota K; Ando K; Shizuta S; Tada T; Tazaki J; Kato Y; Hayano M; Abe M; Hamasaki S; Ohishi M; Nakashima H; Mitsudo K; Nobuyoshi M; Kita T; Imoto Y; Sakata R; Okabayashi H; Hanyu M; Shimamoto M; Nishiwaki N; Komiya T; Kimura T;
Circ Cardiovasc Interv; 2014 Aug; 7(4):482-91. PubMed ID: 25074253
[TBL] [Abstract][Full Text] [Related]
10. The impact of acquired thrombocytopenia on long-term outcomes of patients undergoing elective percutaneous coronary intervention: An analysis of 8,271 consecutive patients.
Liu S; Song C; Zhao Y; Zhu C; Feng L; Dou K; Xu B
Catheter Cardiovasc Interv; 2018 Feb; 91(S1):558-565. PubMed ID: 29368387
[TBL] [Abstract][Full Text] [Related]
11. Mortality Following Cardiovascular and Bleeding Events Occurring Beyond 1 Year After Coronary Stenting: A Secondary Analysis of the Dual Antiplatelet Therapy (DAPT) Study.
Secemsky EA; Yeh RW; Kereiakes DJ; Cutlip DE; Cohen DJ; Steg PG; Cannon CP; Apruzzese PK; D'Agostino RB; Massaro JM; Mauri L;
JAMA Cardiol; 2017 May; 2(5):478-487. PubMed ID: 28297015
[TBL] [Abstract][Full Text] [Related]
12. Relation of periprocedural bleeding complications and long-term outcome in patients undergoing percutaneous coronary revascularization (from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] Trial).
Brugts JJ; Mercado N; Hu S; Guarneri M; Price M; Schatz R; Teirstein P; Wijns W; Serruys PW; O'Neill WW; Boersma E
Am J Cardiol; 2009 Apr; 103(7):917-22. PubMed ID: 19327416
[TBL] [Abstract][Full Text] [Related]
13. Impact of Access Site on Bleeding and Ischemic Events in Patients With Non-ST-Segment Elevation Myocardial Infarction Treated With Prasugrel: The ACCOAST Access Substudy.
Porto I; Bolognese L; Dudek D; Goldstein P; Hamm C; Tanguay JF; Ten Berg J; Widimský P; Le Gall N; Zagar AJ; LeNarz LA; Miller D; Montalescot G;
JACC Cardiovasc Interv; 2016 May; 9(9):897-907. PubMed ID: 27151605
[TBL] [Abstract][Full Text] [Related]
14. Effects of Baseline Thrombocytopenia on In-hospital Outcomes in Patients Undergoing Elective Percutaneous Coronary Intervention.
Shiraishi J; Koshi N; Matsubara Y; Nishimura T; Ito D; Kimura M; Kishita E; Nakagawa Y; Hyogo M; Sawada T
Intern Med; 2019 Jun; 58(12):1681-1688. PubMed ID: 30799350
[TBL] [Abstract][Full Text] [Related]
15. Influence of arterial access site selection on outcomes in primary percutaneous coronary intervention: are the results of randomized trials achievable in clinical practice?
Mamas MA; Ratib K; Routledge H; Neyses L; Fraser DG; de Belder M; Ludman PF; Nolan J;
JACC Cardiovasc Interv; 2013 Jul; 6(7):698-706. PubMed ID: 23769648
[TBL] [Abstract][Full Text] [Related]
16. Thrombocytopenia in patients with atrial fibrillation on oral anticoagulation undergoing percutaneous coronary intervention.
Kiviniemi T; Karjalainen P; Rubboli A; Schlitt A; Tuomainen P; Niemelä M; Laine M; Biancari F; Lip GY; Airaksinen KE
Am J Cardiol; 2013 Aug; 112(4):493-8. PubMed ID: 23672991
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX Trial.
Abtan J; Steg PG; Stone GW; Mahaffey KW; Gibson CM; Hamm CW; Price MJ; Abnousi F; Prats J; Deliargyris EN; White HD; Harrington RA; Bhatt DL;
JACC Cardiovasc Interv; 2016 Sep; 9(18):1905-13. PubMed ID: 27659566
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Impact of in-Hospital-Bleeding in Patients With ST-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention.
Cornara S; Somaschini A; De Servi S; Crimi G; Ferlini M; Baldo A; Camporotondo R; Gnecchi M; Ferrario Ormezzano M; Oltrona Visconti L; De Ferrari GM
Am J Cardiol; 2017 Nov; 120(10):1734-1741. PubMed ID: 28865893
[TBL] [Abstract][Full Text] [Related]
19. Incidence, Predictors, and Outcomes of High-Grade Atrioventricular Block in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention (from the HORIZONS-AMI Trial).
Kosmidou I; Redfors B; Dordi R; Dizon JM; McAndrew T; Mehran R; Ben-Yehuda O; Mintz GS; Stone GW
Am J Cardiol; 2017 May; 119(9):1295-1301. PubMed ID: 28267964
[TBL] [Abstract][Full Text] [Related]
20. Effect of sex difference in clinical presentation (stable coronary artery disease vs unstable angina pectoris or non-ST-elevation myocardial infarction vs ST-elevation myocardial infarction) on 2-year outcomes in patients undergoing percutaneous coronary intervention.
Tang XF; Song Y; Xu JJ; Ma YL; Zhang JH; Yao Y; He C; Wang HH; Jiang P; Jiang L; Liu R; Gao Z; Zhao XY; Qiao SB; Xu B; Yang YJ; Gao RL; Yuan JQ
J Interv Cardiol; 2018 Feb; 31(1):5-14. PubMed ID: 29023996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
